Abstract
Generalized epilepsies are a large group of epilepsies with different clinical aspects and prognosis. Many antiepileptic drugs are available for the treatment of these seizures. This paper reviews the evidence relating to the treatment of this group of epilepsies. Historically, the great majority of patients have been treated with “old” anticonvulsant drugs. Over recent years, there has been a marked improvement in the pharmacological armamentarium of physicians. Today, “new” antiepileptic drugs, such as lamotrigine, levetiracetam, topiramate and zonisamide are useful tools in the treatment of pharmacoresistant epilepsies.
Keywords: Epileptic patients, old antiepileptics, new antiepileptics, epilepsy
Current Clinical Pharmacology
Title: Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies
Volume: 2 Issue: 3
Author(s): Alberto Verrotti, Rita Greco, Raffaella Giannuzzi, Francesco Chiarelli and Giuseppe Latini
Affiliation:
Keywords: Epileptic patients, old antiepileptics, new antiepileptics, epilepsy
Abstract: Generalized epilepsies are a large group of epilepsies with different clinical aspects and prognosis. Many antiepileptic drugs are available for the treatment of these seizures. This paper reviews the evidence relating to the treatment of this group of epilepsies. Historically, the great majority of patients have been treated with “old” anticonvulsant drugs. Over recent years, there has been a marked improvement in the pharmacological armamentarium of physicians. Today, “new” antiepileptic drugs, such as lamotrigine, levetiracetam, topiramate and zonisamide are useful tools in the treatment of pharmacoresistant epilepsies.
Export Options
About this article
Cite this article as:
Verrotti Alberto, Greco Rita, Giannuzzi Raffaella, Chiarelli Francesco and Latini Giuseppe, Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies, Current Clinical Pharmacology 2007; 2 (3) . https://dx.doi.org/10.2174/157488407781668794
DOI https://dx.doi.org/10.2174/157488407781668794 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Bridging Over the Troubled Heterogeneity of SPG-Related Pathologies: Mechanisms Unite What Genetics Divide
Current Molecular Medicine Anticonvulsant, Anxiolytic and Antidepressant Properties of the β-caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems
Current Molecular Pharmacology The Putative Neuroprotective Role of Neuropeptide Y in the Central Nervous System
Current Drug Targets - CNS & Neurological Disorders The Non-ABC Drug Transporter RLIP76 (RALBP-1) Plays a Major Role in the Mechanisms of Drug Resistance
Current Drug Metabolism Editorial [Hot Topic: Drugs and Pregnancy (Guest Editor: Zaneta Kimber-Trojnar)]
Current Pharmaceutical Biotechnology Targeting Cancer and Neuropathy with Histone Deacetylase Inhibitors:Two Birds with One Stone?
Current Cancer Drug Targets Needle in a Haystack: Targeting Specific Glucuronidases Amid the Human Microbiome
Current Enzyme Inhibition Modulation of GABAA Receptors in the Treatment of Epilepsy
Current Pharmaceutical Design Potential Impurities of the Anti-epileptic Drug, Clobazam: Synthesis and Characterization
Letters in Organic Chemistry Synthesis and Evaluation of Phenyliminoindolin-Containing Phenylacetamide Derivatives with the Antidepressant and Anticonvulsant Effects
Medicinal Chemistry Early Age of Migraine Onset is Independently Related to Cognitive Decline and Symptoms of Depression Affect Quality of Life
Current Neurovascular Research Immunology and Epilepsy: Clinical and Experimental Evidence
Current Immunology Reviews (Discontinued) Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry Pedunculopontine Nucleus Stimulation in Intractable Epilepsy: A Recent Patent on Deep Brain Stimulation Therapy
Recent Patents and Topics on Imaging (Discontinued) New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry Cyclooxygenase-2 in Synaptic Signaling
Current Pharmaceutical Design Disorder in Milk Proteins: α-Lactalbumin. Part B. A Multifunctional Whey Protein Acting as an Oligomeric Molten Globular “Oil Container” in the Anti-Tumorigenic Drugs, Liprotides
Current Protein & Peptide Science Physiological Effect and Therapeutic Application of Alpha Lipoic Acid
Current Medicinal Chemistry Some Highlights on Epileptic EEG Processing
Recent Patents on Biomedical Engineering (Discontinued) Synthetic and Natural Protease Inhibitors Provide Insights into Parasite Development, Virulence and Pathogenesis
Current Medicinal Chemistry